You have 9 free searches left this month | for more free features.

Condition

AL Amyloidosis (2)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Alexion Pharmaceuticals (2)

Collaborator

AstraZeneca (1)

Intervention

cael-101 (2)

cyclophosphamide, bortezomib, and dexamethasone (cybord) regimen (1)

daratumumab (1)

placebo (1)

soc: cyclophosphamide, bortezomib, and dexamethasone (cybord) (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

cael-101

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

AL Amyloidosis Trial in Palo Alto, Detroit, Cleveland (CAEL-101, SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD),

Active, not recruiting

AL Amyloidosis

CAEL-101
+2 more

Palo Alto, California
+2 more

Dec 6, 2022

AL Amyloidosis Trial in Worldwide (CAEL-101, Placebo, cyclophosphamide, bortezomib, and dexamethasone (CyBorD) regimen)

Recruiting

AL Amyloidosis

CAEL-101
+2 more

Phoenix, Arizona
+101 more

Aug 4, 2022